scholarly journals Biologic Agents for Periodontal Regeneration and Implant Site Development

2015 ◽  
Vol 2015 ◽  
pp. 1-10 ◽  
Author(s):  
Fernando Suárez-López del Amo ◽  
Alberto Monje ◽  
Miguel Padial-Molina ◽  
ZhiHui Tang ◽  
Hom-Lay Wang

The advancement of molecular mediators or biologic agents has increased tremendously during the last decade in periodontology and dental implantology. Implant site development and reconstruction of the lost periodontium represent main fields in which these molecular mediators have been employed and investigated. Different growth factors trigger different reactions in the tissues of the periodontium at various cellular levels. Proliferation, migration, and differentiation constitute the main target areas of these molecular mediators. It was the purpose of this comprehensive review to describe the origin and rationale, evidence, and the most current understanding of the following biologic agents: Recombinant Human Platelet-Derived Growth Factor-BB (rhPDGF-BB), Enamel Matrix Derivate (EMD), Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF), Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2), Bone Morphogenic Proteins (BMPs, BMP-2 and BMP-7), Teriparatide PTH, and Growth Differential Factor-5 (GDF-5).

2018 ◽  
Vol 4 (3) ◽  
pp. 1196-1202
Author(s):  
Felipe Cid

Regeneration is defined as the reproduction or reconstruction of a lost part or injury of the body in such a way that the architecture and function of the lost or injured tissue are completely restored. The goal of regenerative periodontal therapy is to restore the structure and function of the periodontium. The positive effects of Platelet-rich plasma (PRP) are attributed to the angiogenic, mitogenic and proliferative capacities of growth factors such as platelet-derived growth factor, transforming growth factor and vascular endothelial growth factor. Platelet-rich fibrin (PRF) is a second generation platelet concentrate that allows fibrin membranes enriched with platelets and growth factors to be obtained after starting an anticoagulant-free blood collection without any biomechanical artificial modification. The objective of this review is to know the efficacy of platelet-rich plasma and platelet-rich fibrin in the periodontal regeneration of intrabony defects. The clinical implications for this autologous material are promising. Further long term, larger, multicentred randomized controlled clinical trials are required to determine the effects of PRP and PRF on the regeneration of alveolar bone due to periodontal disease.


2012 ◽  
Vol 83 (5) ◽  
pp. 565-573 ◽  
Author(s):  
Myron Nevins ◽  
Marc L. Nevins ◽  
Nadeem Karimbux ◽  
Soo-Woo Kim ◽  
Peter Schupbach ◽  
...  

2020 ◽  
Vol 10 (02) ◽  
pp. 68-73
Author(s):  
Avaneendra Talwar ◽  
Reshma Amin

Abstract Introduction The alveolar bone, periodontal ligament (PDL), and cementum are the integral structural components invariably subject to changes during periodontal diseases. Many documents on animal and human studies state that the polypeptide growth factors (GFs) have a role in periodontal regeneration. The platelet-rich fibrin (PRF) is in use since the last decade. It has the potential of delivering GFs into vertical osseous defects. Human platelets contain platelet-derived growth factor and transforming growth factor-β in their α granules. These GFs are involved in wound healing and act as promoters of tissue regeneration. The study aimed to obtain histologic evidence, if any, of new attachment in humans, following treatment of osseous defects with 10-1055-s-0040-1714651_00084_ (HA) and PRF mix. Materials and Methods Five maxillary molar teeth with advanced bone loss were treated with porous 10-1055-s-0040-1714651_00084_ (PHA) mixed with PRF. Distobuccal roots were resected and studied histologically for evidence of bone formation, if any, at 1st, 3rd, and the 5th months. Results The PHA was completely resorbed in all the specimens. There was definitive evidence of bone formation at the 3rd month itself with mature lamellar bone with resting and reversal lines at the fifth postoperative month. There was no evidence of new cementum or PDL formation. Conclusion PRF in conjunction with osteoconductive materials prove to accelerate bone formation in vertical osseous defects.


PLoS ONE ◽  
2015 ◽  
Vol 10 (6) ◽  
pp. e0131870 ◽  
Author(s):  
Toshie Nagayasu-Tanaka ◽  
Jun Anzai ◽  
Shu Takaki ◽  
Noriko Shiraishi ◽  
Akio Terashima ◽  
...  

2003 ◽  
Vol 74 (9) ◽  
pp. 1282-1292 ◽  
Author(s):  
Myron Nevins ◽  
Marcelo Camelo ◽  
Marc L. Nevins ◽  
Robert K. Schenk ◽  
Samuel E. Lynch

Sign in / Sign up

Export Citation Format

Share Document